N. Rohmann

发表

Effect of various weight loss interventions on serum NT-proBNP concentration in severe obese subjects without clinical manifest heart failure

S. Schreiber, A. Franke, M. Laudes, 2021, Scientific Reports.

Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation.

A. Franke, M. Laudes, A. Bosy-Westphal, 2020, The Journal of clinical endocrinology and metabolism.

A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes

C. Kaleta, A. Franke, M. Laudes, 2022, Gut microbes.

Circulating sDPP-4 is increased in human subjects with obesity and related metabolic abnormalities and is altered in subjects hospitalized for severe COVID-19 infection

A. Franke, M. Laudes, C. Geisler, 2021 .

Cohort profile: the Food Chain Plus (FoCus) cohort

U. Nöthlings, W. Lieb, P. Rosenstiel, 2022, European Journal of Epidemiology.

Differential Effects of Obesity, Hyperlipidaemia, Dietary Intake and Physical Inactivity on Type I versus Type IV Allergies

A. Franke, M. Laudes, C. Bang, 2022, Nutrients.

Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection

P. Rosenstiel, M. Laudes, C. Geisler, 2022, Frontiers in Immunology.

Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections

P. Rosenstiel, A. Franke, M. Laudes, 2020, International Journal of Obesity.

Microbiota in Health and Disease—Potential Clinical Applications

T. Pischon, M. Laudes, J. Bouwman, 2021, Nutrients.

BMI, Alcohol Consumption and Gut Microbiome Species Richness Are Related to Structural and Functional Neurological Abnormalities

A. Franke, M. Laudes, C. Geisler, 2021, Nutrients.

Physical activity‐induced alterations of the gut microbiota are BMI dependent

M. Laudes, C. Geisler, H. Köfeler, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Dipeptidylpeptidase (DPP)-4 inhibitor therapy increases circulating levels of anti-inflammatory soluble frizzle receptor protein (sFRP)-5 which is decreased in severe COVID-19 disease

M. Laudes, C. Geisler, F. Tran, 2022, Scientific Reports.

A Prospective Analysis of the Metyrapone Short Test Using Targeted and Untargeted Metabolomics

M. Laudes, C. Geisler, D. Schulte, 2023, Neuroendocrinology.

Effects of lifestyle and associated diseases on serum CC16 suggest complex interactions among metabolism, heart and lungs.

P. Rosenstiel, M. Laudes, C. Geisler, 2023, Journal of advanced research.

Metabolic and lifestyle factors accelerate disease onset and alter gut microbiome in inflammatory non-communicable diseases

D. Schulte, T. Demetrowitsch, K. Türk, 2024, BMC medicine.